CS logo
small CS logo
Hopital de la Croix Rousse

Lyon, France
Groupement Hospitalier Nord

About Hopital de la Croix Rousse


L'hôpital de la Croix-Rousse, intégré au Groupement Hospitalier Nord, est l'un des quatre grands pôles hospitaliers des hospices civils de Lyon.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hospices Civils de Lyon
111
Gilead Sciences
16
Intergroupe Francophone de Cancerologie Thoracique
9
ANRS, Emerging Infectious Diseases
8
Federation Francophone de Cancerologie Digestive
8
Centre Hospitalier Universitaire de Saint Etienne
6
GERCOR - Multidisciplinary Oncology Cooperative Group
5
Hoffmann-La Roche
5
Janssen Research & Development, LLC
5
Société des Produits Nestlé (SPN)
5
Hôpital de la Croix-Rousse
4
Total Rows: 100

Clinical Trials at Hopital de la Croix Rousse


During the past decade, Hopital de la Croix Rousse conducted 232 clinical trials. In the 10-year time frame, 232 clinical trials started and 34 clinical trials were completed, i.e. on average, 14.7% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 18 clinical trials were completed. i.e. 23.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years28283737282832322929373727279955224411336655774422Started TrialsCompleted Trails201520162017201820192020202120222023010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
1999-01-01
Unknown status
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
2002-05-01
2010-09-01
Completed
195
Combination Chemotherapy in Treating Women With Stage I Breast Cancer
2002-08-01
2013-06-01
Completed
1,512
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
2003-11-01
Unknown status
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
2001-04-01
Unknown status
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
2004-05-25
2007-07-06
Completed
84
Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
2004-11-01
2010-06-30
Completed
342

Rows per page:

1–100 of 348

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hopital de la Croix Rousse" #1 sponsor was "Hospices Civils de Lyon" with 111 trials, followed by "Gilead Sciences" with 16 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 9 trials sponsored, "ANRS, Emerging Infectious Diseases" with 8 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 8 trials sponsored. Other sponsors include 191 different institutions and companies that sponsored additional 129 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de la Croix Rousse" #1 collaborator was "Ministry of Health, France" with 9 trials as a collaborator, "Hospices Civils de Lyon" with 4 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 3 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 109 different institutions and companies that were collaborators in the rest 105 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHospices Civils de Lyon: 111Hospices Civils de Lyon: 111Gilead Sciences: 16Gilead Sciences: 16IntergroupeFrancophone deCancerologieThoracique: 9IntergroupeFrancophone deCancerologieThoracique: 9ANRS, EmergingInfectious Diseases: 8ANRS, EmergingInfectious Diseases: 8Federation Francophonede CancerologieDigestive: 8Federation Francophonede CancerologieDigestive: 8Centre HospitalierUniversitaire de SaintEtienne: 6Centre HospitalierUniversitaire de SaintEtienne: 6GERCOR -MultidisciplinaryOncology CooperativeGroup: 5GERCOR -MultidisciplinaryOncology CooperativeGroup: 5Hoffmann-La Roche: 5Hoffmann-La Roche: 5Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5Société des ProduitsNestlé (SPN): 5Société des ProduitsNestlé (SPN): 5

Created with Highcharts 11.1.0Top CollaboratorsMinistry of Health, France: 9Ministry of Health, France: 9Hospices Civils de Lyon: 4Hospices Civils de Lyon: 4GERCOR -MultidisciplinaryOncology CooperativeGroup: 3GERCOR -MultidisciplinaryOncology CooperativeGroup: 3Institut National de laSanté Et de laRecherche Médicale,France: 3Institut National de laSanté Et de laRecherche Médicale,France: 3Pfizer: 3Pfizer: 3UNICANCER: 3UNICANCER: 3ARCAGY/ GINECO GROUP: 2ARCAGY/ GINECO GROUP: 2AstraZeneca: 2AstraZeneca: 2Biocompatibles UK Ltd: 2Biocompatibles UK Ltd: 2European Organisationfor Research andTreatment of Cancer -EORTC: 2European Organisationfor Research andTreatment of Cancer -EORTC: 2

Clinical Trials Conditions at Hopital de la Croix Rousse


According to Clinical.Site data, the most researched conditions in "Hopital de la Croix Rousse" are "HIV" (9 trials), "HIV Infections" (9 trials), "Acute Respiratory Distress Syndrome" (7 trials), "Hepatocellular Carcinoma" (7 trials) and "Breast Cancer" (6 trials). Many other conditions were trialed in "Hopital de la Croix Rousse" in a lesser frequency.

Clinical Trials Intervention Types at Hopital de la Croix Rousse


Most popular intervention types in "Hopital de la Croix Rousse" are "Drug" (146 trials), "Other" (74 trials), "Procedure" (51 trials), "Device" (46 trials) and "Biological" (22 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (31 trials), "Gemcitabine" (5 trials), "JNJ-73763989" (5 trials), "fluorouracil" (5 trials) and "Aflibercept" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Hopital de la Croix Rousse


The vast majority of trials in "Hopital de la Croix Rousse" are 317 trials for "All" genders, 28 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Hopital de la Croix Rousse


Currently, there are 94 active trials in "Hopital de la Croix Rousse". 6 are not yet recruiting, 60 are recruiting, 27 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 197 completed trials in Hopital de la Croix Rousse, undefined suspended trials, and 22 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital de la Croix Rousse, 5 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 90 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 90Not Applicable: 90Phase 3: 74Phase 3: 74Phase 2: 65Phase 2: 65Phase 4: 12Phase 4: 12Phase 1: 5Phase 1: 5Early Phase 1: 2Early Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 197Completed: 197Recruiting: 60Recruiting: 60Unknown status: 33Unknown status: 33Active, not recruiting: 27Active, not recruiting: 27Terminated: 22Terminated: 22Not yet recruiting: 6Not yet recruiting: 6Withdrawn: 2Withdrawn: 2Enrolling by invitation: 1Enrolling by invitation: 1

Departments of Hopital de la Croix Rousse


Hopital de la Croix Rousse has several departments that took part in Clinical trials: "Service de Pneumologie, Hôpital de la Croix Rousse" - 8 trials
Departments List
Total Rows: 1